BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34628440)

  • 1. HIV-associated wasting prevalence in the era of modern antiretroviral therapy.
    Siddiqui J; Samuel SK; Hayward B; Wirka KA; Deering KL; Harshaw Q; Phillips A; Harbour M
    AIDS; 2022 Jan; 36(1):127-135. PubMed ID: 34628440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of HIV-associated wasting in the era of modern antiretroviral therapy.
    Siddiqui J; Samuel SK; Hayward B; Wirka KA; Deering KL; Harshaw Q; Phillips A; Harbour M
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1180-1189. PubMed ID: 35939048
    [No Abstract]   [Full Text] [Related]  

  • 3. Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort.
    Wohlfeiler MB; Weber RP; Brunet L; Siddiqui J; Harbour M; Phillips AL; Hayward B; Fusco JS; Hsu RK; Fusco GP
    AIDS Res Hum Retroviruses; 2023 Dec; 39(12):636-643. PubMed ID: 37489298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
    Wohlfeiler MB; Weber RP; Brunet L; Siddiqui J; Harbour M; Phillips AL; Hayward B; Fusco JS; Hsu RK; Fusco GP
    AIDS Res Hum Retroviruses; 2024 Mar; ():. PubMed ID: 38481376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA.
    Schneider G; Juday T; Wentworth C; Lanes S; Hebden T; Seekins D
    AIDS Care; 2013; 25(11):1470-6. PubMed ID: 23517139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Despite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC: a retrospective analysis.
    Goldstein D; Hardy WD; Monroe A; Hou Q; Hart R; Terzian A;
    BMC Public Health; 2020 Apr; 20(1):509. PubMed ID: 32299421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States.
    Korsnes JS; Goodwin BB; Murray M; Candrilli SD
    Ann Pharmacother; 2016 Dec; 50(12):989-1000. PubMed ID: 27439947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States.
    McComsey GA; Lingohr-Smith M; Rogers R; Lin J; Donga P
    Adv Ther; 2021 Sep; 38(9):4961-4974. PubMed ID: 34390465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
    Kong AM; Pozen A; Anastos K; Kelvin EA; Nash D
    AIDS Patient Care STDS; 2019 Mar; 33(3):93-103. PubMed ID: 30844304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of neuropsychiatric disorders in patients living with HIV-1 treated with antiretroviral therapies-A perspective from US Medicaid data.
    Chow W; Hardy H; Song J; Connolly N; Wu B
    Int J STD AIDS; 2022 Mar; 33(3):275-281. PubMed ID: 34903117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic characterization of mild, moderate, and severe systemic lupus erythematosus: Real-world observation across payer channels in the United States.
    Wu SS; Perry A; Tkacz J; Bryant G
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1010-1020. PubMed ID: 37610115
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data.
    Monroe AK; Fleishman JA; Voss CC; Keruly JC; Nijhawan AE; Agwu AL; Aberg JA; Rutstein RM; Moore RD; Gebo KA;
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):82-89. PubMed ID: 28797023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program.
    Li P; Prajapati G; Geng Z; Ladage VP; Arduino JM; Watson DL; Gross R; Doshi JA
    AIDS Behav; 2024 Mar; 28(3):1002-1014. PubMed ID: 37889363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in Medical Care Among Insured Adolescents and Young Adults With Diagnosed HIV Infection, United States, 2010-2014.
    Tanner MR; Bush T; Nesheim SR; Weidle PJ; Byrd KK
    Public Health Rep; 2022; 137(4):721-729. PubMed ID: 34133247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.
    Cohen J; Beaubrun A; Bashyal R; Huang A; Li J; Baser O
    AIDS Res Ther; 2020 Apr; 17(1):12. PubMed ID: 32238169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.